Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth

Erin A.S. Clark, Steven J. Weiner, Dwight J. Rouse, Brian M. Mercer, Uma M. Reddy, Jay D. Iams, Ronald J. Wapner, Yoram Sorokin, Fergal D. Malone, Mary J. O'sullivan, Alan M. Peaceman, Gary Hankins, Donald J. Dudley, Steve N. Caritis

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective To evaluate the association of magnesium sulfate (MgSO 4 ) exposure and candidate gene polymorphisms with adverse neurodevelopmental outcomes following preterm birth. Study Design We performed a nested case–control analysis of a randomized trial of maternal MgSO 4 before anticipated preterm birth for the prevention of cerebral palsy (CP). Cases were children who died within 1 year of life or were survivors with abnormal neurodevelopment at age 2 years. Controls were race- and sex-matched survivors with normal neurodevelopment. We analyzed 45 candidate gene polymorphisms in inflammation, coagulation, and vascular regulation pathways and their association with (1) psychomotor delay, (2) mental delay, (3) CP, and (4) combined outcome of death/CP. Logistic regression analyses, conditional on maternal race and child sex, and adjusted for treatment group, gestational age at birth and maternal education, were performed. Results Four hundred and six subjects, 211 cases and 195 controls, were analyzed. The strongest association was for IL6R (rs 4601580) in which each additional copy of the minor allele was associated with an increased risk of psychomotor delay (adjusted odds ratio 3.3; 95% confidence interval, 1.7–6.5; p < 0.001). Conclusion Candidate gene polymorphisms are associated with death and adverse neurodevelopmental outcomes following preterm birth. MgSO 4 may abrogate this genotype association for some loci.

Original languageEnglish (US)
JournalAmerican Journal of Perinatology
DOIs
StateAccepted/In press - Mar 6 2018

Fingerprint

Magnesium Sulfate
Premature Birth
Cerebral Palsy
Mothers
Survivors
Genes
Gestational Age
Blood Vessels
Logistic Models
Alleles
Odds Ratio
Genotype
Regression Analysis
Parturition
Confidence Intervals
Inflammation
Education
Therapeutics

Keywords

  • candidate genes
  • magnesium sulfate
  • mental developmental delay
  • neurodevelopmental delay
  • polymorphisms
  • preterm birth
  • psychomotor delay
  • single-nucleotide polymorphisms

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Clark, E. A. S., Weiner, S. J., Rouse, D. J., Mercer, B. M., Reddy, U. M., Iams, J. D., ... Caritis, S. N. (Accepted/In press). Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth. American Journal of Perinatology. https://doi.org/10.1055/s-0038-1635109

Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth. / Clark, Erin A.S.; Weiner, Steven J.; Rouse, Dwight J.; Mercer, Brian M.; Reddy, Uma M.; Iams, Jay D.; Wapner, Ronald J.; Sorokin, Yoram; Malone, Fergal D.; O'sullivan, Mary J.; Peaceman, Alan M.; Hankins, Gary; Dudley, Donald J.; Caritis, Steve N.

In: American Journal of Perinatology, 06.03.2018.

Research output: Contribution to journalArticle

Clark, EAS, Weiner, SJ, Rouse, DJ, Mercer, BM, Reddy, UM, Iams, JD, Wapner, RJ, Sorokin, Y, Malone, FD, O'sullivan, MJ, Peaceman, AM, Hankins, G, Dudley, DJ & Caritis, SN 2018, 'Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth', American Journal of Perinatology. https://doi.org/10.1055/s-0038-1635109
Clark, Erin A.S. ; Weiner, Steven J. ; Rouse, Dwight J. ; Mercer, Brian M. ; Reddy, Uma M. ; Iams, Jay D. ; Wapner, Ronald J. ; Sorokin, Yoram ; Malone, Fergal D. ; O'sullivan, Mary J. ; Peaceman, Alan M. ; Hankins, Gary ; Dudley, Donald J. ; Caritis, Steve N. / Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth. In: American Journal of Perinatology. 2018.
@article{5c0f4e8a4aed4cb4bc547e607e4f4207,
title = "Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth",
abstract = "Objective To evaluate the association of magnesium sulfate (MgSO 4 ) exposure and candidate gene polymorphisms with adverse neurodevelopmental outcomes following preterm birth. Study Design We performed a nested case–control analysis of a randomized trial of maternal MgSO 4 before anticipated preterm birth for the prevention of cerebral palsy (CP). Cases were children who died within 1 year of life or were survivors with abnormal neurodevelopment at age 2 years. Controls were race- and sex-matched survivors with normal neurodevelopment. We analyzed 45 candidate gene polymorphisms in inflammation, coagulation, and vascular regulation pathways and their association with (1) psychomotor delay, (2) mental delay, (3) CP, and (4) combined outcome of death/CP. Logistic regression analyses, conditional on maternal race and child sex, and adjusted for treatment group, gestational age at birth and maternal education, were performed. Results Four hundred and six subjects, 211 cases and 195 controls, were analyzed. The strongest association was for IL6R (rs 4601580) in which each additional copy of the minor allele was associated with an increased risk of psychomotor delay (adjusted odds ratio 3.3; 95{\%} confidence interval, 1.7–6.5; p < 0.001). Conclusion Candidate gene polymorphisms are associated with death and adverse neurodevelopmental outcomes following preterm birth. MgSO 4 may abrogate this genotype association for some loci.",
keywords = "candidate genes, magnesium sulfate, mental developmental delay, neurodevelopmental delay, polymorphisms, preterm birth, psychomotor delay, single-nucleotide polymorphisms",
author = "Clark, {Erin A.S.} and Weiner, {Steven J.} and Rouse, {Dwight J.} and Mercer, {Brian M.} and Reddy, {Uma M.} and Iams, {Jay D.} and Wapner, {Ronald J.} and Yoram Sorokin and Malone, {Fergal D.} and O'sullivan, {Mary J.} and Peaceman, {Alan M.} and Gary Hankins and Dudley, {Donald J.} and Caritis, {Steve N.}",
year = "2018",
month = "3",
day = "6",
doi = "10.1055/s-0038-1635109",
language = "English (US)",
journal = "American Journal of Perinatology",
issn = "0735-1631",
publisher = "Thieme Medical Publishers",

}

TY - JOUR

T1 - Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth

AU - Clark, Erin A.S.

AU - Weiner, Steven J.

AU - Rouse, Dwight J.

AU - Mercer, Brian M.

AU - Reddy, Uma M.

AU - Iams, Jay D.

AU - Wapner, Ronald J.

AU - Sorokin, Yoram

AU - Malone, Fergal D.

AU - O'sullivan, Mary J.

AU - Peaceman, Alan M.

AU - Hankins, Gary

AU - Dudley, Donald J.

AU - Caritis, Steve N.

PY - 2018/3/6

Y1 - 2018/3/6

N2 - Objective To evaluate the association of magnesium sulfate (MgSO 4 ) exposure and candidate gene polymorphisms with adverse neurodevelopmental outcomes following preterm birth. Study Design We performed a nested case–control analysis of a randomized trial of maternal MgSO 4 before anticipated preterm birth for the prevention of cerebral palsy (CP). Cases were children who died within 1 year of life or were survivors with abnormal neurodevelopment at age 2 years. Controls were race- and sex-matched survivors with normal neurodevelopment. We analyzed 45 candidate gene polymorphisms in inflammation, coagulation, and vascular regulation pathways and their association with (1) psychomotor delay, (2) mental delay, (3) CP, and (4) combined outcome of death/CP. Logistic regression analyses, conditional on maternal race and child sex, and adjusted for treatment group, gestational age at birth and maternal education, were performed. Results Four hundred and six subjects, 211 cases and 195 controls, were analyzed. The strongest association was for IL6R (rs 4601580) in which each additional copy of the minor allele was associated with an increased risk of psychomotor delay (adjusted odds ratio 3.3; 95% confidence interval, 1.7–6.5; p < 0.001). Conclusion Candidate gene polymorphisms are associated with death and adverse neurodevelopmental outcomes following preterm birth. MgSO 4 may abrogate this genotype association for some loci.

AB - Objective To evaluate the association of magnesium sulfate (MgSO 4 ) exposure and candidate gene polymorphisms with adverse neurodevelopmental outcomes following preterm birth. Study Design We performed a nested case–control analysis of a randomized trial of maternal MgSO 4 before anticipated preterm birth for the prevention of cerebral palsy (CP). Cases were children who died within 1 year of life or were survivors with abnormal neurodevelopment at age 2 years. Controls were race- and sex-matched survivors with normal neurodevelopment. We analyzed 45 candidate gene polymorphisms in inflammation, coagulation, and vascular regulation pathways and their association with (1) psychomotor delay, (2) mental delay, (3) CP, and (4) combined outcome of death/CP. Logistic regression analyses, conditional on maternal race and child sex, and adjusted for treatment group, gestational age at birth and maternal education, were performed. Results Four hundred and six subjects, 211 cases and 195 controls, were analyzed. The strongest association was for IL6R (rs 4601580) in which each additional copy of the minor allele was associated with an increased risk of psychomotor delay (adjusted odds ratio 3.3; 95% confidence interval, 1.7–6.5; p < 0.001). Conclusion Candidate gene polymorphisms are associated with death and adverse neurodevelopmental outcomes following preterm birth. MgSO 4 may abrogate this genotype association for some loci.

KW - candidate genes

KW - magnesium sulfate

KW - mental developmental delay

KW - neurodevelopmental delay

KW - polymorphisms

KW - preterm birth

KW - psychomotor delay

KW - single-nucleotide polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=85044097010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044097010&partnerID=8YFLogxK

U2 - 10.1055/s-0038-1635109

DO - 10.1055/s-0038-1635109

M3 - Article

JO - American Journal of Perinatology

JF - American Journal of Perinatology

SN - 0735-1631

ER -